Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Ozzoude M, Varriano B, Beaton D, Ramirez J, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Rabin J, Goubran M, Kwan D, Roberts A, Bartha R, Symons S, Tan B, Swartz RH, Abrahao A, Saposnik G, Masellis M, Lang AE, Marras C, Zinman L, Shoesmith C, Borrie M, Fischer CE, Frank A, Freedman M, Montero-Odasso M, Kumar S, Pasternak S, Strother SC, Pollock BG, Rajji TK, Seitz D, Tang-Wai DF, Turnbull J, Dowlatshahi D, Hassan A, Casaubon L, Mandzia J, Sahlas D, Breen DP, Grimes D, Jog M, Steeves TDL, Arnott SR, Black SE, Finger E, Tartaglia MC. Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases. GeroScience 2022;44:1575-1598. [PMID: 35294697 DOI: 10.1007/s11357-022-00539-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Accepted: 02/22/2022] [Indexed: 11/24/2022] Open

For:	Ozzoude M, Varriano B, Beaton D, Ramirez J, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Rabin J, Goubran M, Kwan D, Roberts A, Bartha R, Symons S, Tan B, Swartz RH, Abrahao A, Saposnik G, Masellis M, Lang AE, Marras C, Zinman L, Shoesmith C, Borrie M, Fischer CE, Frank A, Freedman M, Montero-Odasso M, Kumar S, Pasternak S, Strother SC, Pollock BG, Rajji TK, Seitz D, Tang-Wai DF, Turnbull J, Dowlatshahi D, Hassan A, Casaubon L, Mandzia J, Sahlas D, Breen DP, Grimes D, Jog M, Steeves TDL, Arnott SR, Black SE, Finger E, Tartaglia MC. Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases. GeroScience 2022;44:1575-1598. [PMID: 35294697 DOI: 10.1007/s11357-022-00539-x] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Accepted: 02/22/2022] [Indexed: 11/24/2022] Open

Number

Cited by Other Article(s)

Owens CD, Pinto CB, Szarvas Z, Muranyi M, da C. Pinaffi-Langley AC, Peterfi A, Mukli P, Detwiler S, Olay L, Kaposzta Z, Smith K, Kirkpatrick AC, Saleh Velez F, Tarantini S, Csiszar A, Ungvari ZI, Prodan CI, Yabluchanskiy A. COVID-19 Exacerbates Neurovascular Uncoupling and Contributes to Endothelial Dysfunction in Patients with Mild Cognitive Impairment. Biomolecules 2024;14:1621. [PMID: 39766328 PMCID: PMC11726736 DOI: 10.3390/biom14121621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2024] [Revised: 12/04/2024] [Accepted: 12/12/2024] [Indexed: 01/15/2025] Open

Affiliation(s)

Cameron D. Owens Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Camila B. Pinto Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Zsofia Szarvas Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary
Mihaly Muranyi Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Ana Clara da C. Pinaffi-Langley Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Department of Nutritional Sciences, College of Allied Health, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA
Anna Peterfi Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary
Peter Mukli Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary Department of Physiology, Faculty of Medicine, Semmelweis University, 1087 Budapest, Hungary
Sam Detwiler Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Lauren Olay Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Zalan Kaposzta Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary Department of Physiology, Faculty of Medicine, Semmelweis University, 1087 Budapest, Hungary
Kenneth Smith Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA;
Angelia C. Kirkpatrick Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA; (A.C.K.); (C.I.P.) Cardiovascular Disease Section, Department of Medicine, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA
Faddi Saleh Velez Department of Neurology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA;
Stefano Tarantini Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
Anna Csiszar Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary
Zoltan I. Ungvari Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA
Calin I. Prodan Veterans Affairs Medical Center, Oklahoma City, OK 73104, USA; (A.C.K.); (C.I.P.) Department of Neurology, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA;
Andriy Yabluchanskiy Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences, Oklahoma City, OK 73117, USA; (C.D.O.); (C.B.P.); (Z.S.); (M.M.); (A.C.d.C.P.-L.); (A.P.); (P.M.); (S.D.); (L.O.); (Z.K.); (S.T.); (A.C.); (Z.I.U.) Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences, Oklahoma City, OK 73104, USA Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Collapse

Tang WK, Hui E, Leung TWH. Loss of empathy in stroke. Front Psychol 2024;15:1451431. [PMID: 39654928 PMCID: PMC11626759 DOI: 10.3389/fpsyg.2024.1451431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2024] [Accepted: 11/11/2024] [Indexed: 12/12/2024] Open

Khadhraoui E, Nickl-Jockschat T, Henkes H, Behme D, Müller SJ. Automated brain segmentation and volumetry in dementia diagnostics: a narrative review with emphasis on FreeSurfer. Front Aging Neurosci 2024;16:1459652. [PMID: 39291276 PMCID: PMC11405240 DOI: 10.3389/fnagi.2024.1459652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Accepted: 08/19/2024] [Indexed: 09/19/2024] Open

Abstract BackgroundDementia can be caused by numerous different diseases that present variable clinical courses and reveal multiple patterns of brain atrophy, making its accurate early diagnosis by conventional examinative means challenging. Although highly accurate and powerful, magnetic resonance imaging (MRI) currently plays only a supportive role in dementia diagnosis, largely due to the enormous volume and diversity of data it generates. AI-based software solutions/algorithms that can perform automated segmentation and volumetry analyses of MRI data are being increasingly used to address this issue. Numerous commercial and non-commercial software solutions for automated brain segmentation and volumetry exist, with FreeSurfer being the most frequently used.ObjectivesThis Review is an account of the current situation regarding the application of automated brain segmentation and volumetry to dementia diagnosis.MethodsWe performed a PubMed search for “FreeSurfer AND Dementia” and obtained 493 results. Based on these search results, we conducted an in-depth source analysis to identify additional publications, software tools, and methods. Studies were analyzed for design, patient collective, and for statistical evaluation (mathematical methods, correlations).ResultsIn the studies identified, the main diseases and cohorts represented were Alzheimer’s disease (n = 276), mild cognitive impairment (n = 157), frontotemporal dementia (n = 34), Parkinson’s disease (n = 29), dementia with Lewy bodies (n = 20), and healthy controls (n = 356). The findings and methods of a selection of the studies identified were summarized and discussed.ConclusionOur evaluation showed that, while a large number of studies and software solutions are available, many diseases are underrepresented in terms of their incidence. There is therefore plenty of scope for targeted research. Collapse

Fu X, Sun P, Zhang X, Zhu D, Qin Q, Lu J, Wang J. GABA in the anterior cingulate cortex mediates the association of white matter hyperintensities with executive function: a magnetic resonance spectroscopy study. Aging (Albany NY) 2024;16:4282-4298. [PMID: 38441529 PMCID: PMC10968699 DOI: 10.18632/aging.205585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Accepted: 01/24/2024] [Indexed: 03/22/2024]

Wang YTT, Rosa-Neto P, Gauthier S. Advanced brain imaging for the diagnosis of Alzheimer disease. Curr Opin Neurol 2023;36:481-490. [PMID: 37639461 DOI: 10.1097/wco.0000000000001198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/31/2023]

Ozzoude M, Varriano B, Beaton D, Ramirez J, Adamo S, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Goubran M, Kwan D, Roberts A, Bartha R, Symons S, Tan B, Swartz RH, Abrahao A, Saposnik G, Masellis M, Lang AE, Marras C, Zinman L, Shoesmith C, Borrie M, Fischer CE, Frank A, Freedman M, Montero-Odasso M, Kumar S, Pasternak S, Strother SC, Pollock BG, Rajji TK, Seitz D, Tang-Wai DF, Turnbull J, Dowlatshahi D, Hassan A, Casaubon L, Mandzia J, Sahlas D, Breen DP, Grimes D, Jog M, Steeves TDL, Arnott SR, Black SE, Finger E, Rabin J, Tartaglia MC. White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases. Alzheimers Res Ther 2023;15:114. [PMID: 37340319 PMCID: PMC10280981 DOI: 10.1186/s13195-023-01257-y] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Accepted: 06/01/2023] [Indexed: 06/22/2023]

Abstract

BACKGROUND

Neuropsychiatric symptoms (NPS) are a core feature of most neurodegenerative and cerebrovascular diseases. White matter hyperintensities and brain atrophy have been implicated in NPS. We aimed to investigate the relative contribution of white matter hyperintensities and cortical thickness to NPS in participants across neurodegenerative and cerebrovascular diseases.

METHODS

Five hundred thirteen participants with one of these conditions, i.e. Alzheimer's Disease/Mild Cognitive Impairment, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Parkinson's Disease, or Cerebrovascular Disease, were included in the study. NPS were assessed using the Neuropsychiatric Inventory - Questionnaire and grouped into hyperactivity, psychotic, affective, and apathy subsyndromes. White matter hyperintensities were quantified using a semi-automatic segmentation technique and FreeSurfer cortical thickness was used to measure regional grey matter loss.

RESULTS

Although NPS were frequent across the five disease groups, participants with frontotemporal dementia had the highest frequency of hyperactivity, apathy, and affective subsyndromes compared to other groups, whilst psychotic subsyndrome was high in both frontotemporal dementia and Parkinson's disease. Results from univariate and multivariate results showed that various predictors were associated with neuropsychiatric subsyndromes, especially cortical thickness in the inferior frontal, cingulate, and insula regions, sex(female), global cognition, and basal ganglia-thalamus white matter hyperintensities.

CONCLUSIONS

In participants with neurodegenerative and cerebrovascular diseases, our results suggest that smaller cortical thickness and white matter hyperintensity burden in several cortical-subcortical structures may contribute to the development of NPS. Further studies investigating the mechanisms that determine the progression of NPS in various neurodegenerative and cerebrovascular diseases are needed.

Collapse

Affiliation(s)

Miracle Ozzoude Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th floor 6KD-407, Toronto, ON, M5T 2S8, Canada L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada Department of Psychology, Faculty of Health, York University, Toronto, ON, Canada
Brenda Varriano Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th floor 6KD-407, Toronto, ON, M5T 2S8, Canada Central Michigan University College of Medicine, Mount Pleasant, MI, USA
Derek Beaton Data Science & Advanced Analytic, St. Michael's Hospital, Toronto, ON, Canada
Joel Ramirez L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada
Sabrina Adamo Graduate Department of Psychological Clinical Science, University of Toronto Scarborough, Scarborough, ON, Canada
Melissa F Holmes L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada
Christopher J M Scott L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada
Fuqiang Gao L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada
Kelly M Sunderland Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada
Paula McLaughlin Nova Scotia Health, Halifax, NS, Canada
Maged Goubran Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Donna Kwan Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada Queen's University, Kingston, ON, Canada
Angela Roberts Roxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL, USA School of Communication Sciences and Disorders, Faculty of Health Sciences, Western University, London, ON, Canada
Robert Bartha Robarts Research Institute, Western University, London, ON, Canada
Sean Symons Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Brian Tan Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada
Richard H Swartz Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Heart & Stroke Foundation Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Agessandro Abrahao Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada
Gustavo Saposnik Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
Mario Masellis Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada
Anthony E Lang Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Edmond J Safra Program for Parkinson Disease, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
Connie Marras Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Edmond J Safra Program for Parkinson Disease, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
Lorne Zinman Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada
Christen Shoesmith Department of Clinical Neurological Sciences, Western University, London, ON, Canada
Michael Borrie Robarts Research Institute, Western University, London, ON, Canada Department of Clinical Neurological Sciences, Western University, London, ON, Canada Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Corinne E Fischer Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada
Andrew Frank Department of Medicine (Neurology), University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada Bruyère Research Institute, Ottawa, ON, Canada
Morris Freedman Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Division of Neurology, Baycrest Health Sciences, Toronto, ON, Canada
Manuel Montero-Odasso Department of Clinical Neurological Sciences, Western University, London, ON, Canada Lawsone Health Research Institute, London, ON, Canada Gait and Brain Lab, Parkwood Institute, London, ON, Canada
Sanjeev Kumar Department of Psychiatry, University of Toronto, Toronto, ON, Canada Adult Neurodevelopment and Geriatric Psychiatry, Centre for Addiction and Mental Health, Toronto, ON, Canada
Stephen Pasternak Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Stephen C Strother Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
Bruce G Pollock Department of Psychiatry, University of Toronto, Toronto, ON, Canada Adult Neurodevelopment and Geriatric Psychiatry, Centre for Addiction and Mental Health, Toronto, ON, Canada
Tarek K Rajji Department of Psychiatry, University of Toronto, Toronto, ON, Canada Adult Neurodevelopment and Geriatric Psychiatry, Centre for Addiction and Mental Health, Toronto, ON, Canada Toronto Dementia Research Alliance, University of Toronto, Toronto, ON, Canada
Dallas Seitz Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
David F Tang-Wai Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Memory Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada
John Turnbull Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada Department of Medicine, McMaster University, Hamilton, ON, Canada
Dar Dowlatshahi Department of Medicine (Neurology), University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada
Ayman Hassan Thunder Bay Regional Health Research Institute, Thunder Bay, ON, Canada
Leanne Casaubon Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada
Jennifer Mandzia Department of Clinical Neurological Sciences, Western University, London, ON, Canada Schulich School of Medicine and Dentistry, Western University, London, ON, Canada St. Joseph's Healthcare Centre, London, ON, Canada
Demetrios Sahlas Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada Department of Medicine, McMaster University, Hamilton, ON, Canada
David P Breen Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
David Grimes Department of Medicine (Neurology), University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada
Mandar Jog Department of Clinical Neurological Sciences, Western University, London, ON, Canada Schulich School of Medicine and Dentistry, Western University, London, ON, Canada London Health Sciences Centre, London, ON, Canada
Thomas D L Steeves Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
Stephen R Arnott Rotman Research Institute of Baycrest Centre, Toronto, ON, Canada
Sandra E Black L.C. Campbell Cognitive Neurology Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Heart & Stroke Foundation Canadian Partnership for Stroke Recovery, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Toronto Dementia Research Alliance, University of Toronto, Toronto, ON, Canada
Elizabeth Finger Department of Clinical Neurological Sciences, Western University, London, ON, Canada Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
Jennifer Rabin Dr. Sandra Black Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada
Maria Carmela Tartaglia Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th floor 6KD-407, Toronto, ON, M5T 2S8, Canada. Department of Medicine, Division of Neurology, University of Toronto, Toronto, ON, Canada. Toronto Dementia Research Alliance, University of Toronto, Toronto, ON, Canada. Memory Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.

Collapse